1,723 research outputs found
Presentation to Dr. Carlsen
No full textDeaf Heritage: A Narrative History of Deaf America presented to Dr. Charles J. Carlsen, the third president of JCCC by author Jack R. Ganno
Survey-based Indicators of Regional Labour Markets and Interregional Migration in Norway
No full textA rich set of regional labour market variables is utilised to explain interregional migration in Norway. In particular, regional indicators of labour market pressure are computed from survey data in which respondents are asked to evaluate local job prospects in their resident municipality and the surroundings. Mean satisfaction with local job prospects reported by respondents in a region and related survey-based indicators have a positive and significant impact on net in-migration to the region, also when controlling for traditional measures of regional labour market conditions, such as regional unemployment and wage differentials. Our results suggest that surveys may provide useful information about regional labour markets.Interregional migration; regional labour markets; survey data
Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN
No full textAim: The aims of part II is to review the current recommended treatment of exercise-induced asthma (EIA), respiratory and allergic disorders in sports, to review the evidence on possible improvement of performance in sports by asthma drugs and to make recommendations for their treatment.
Methods: The literature cited with respect to the treatment of exercise induced asthma in athletes (and in asthma patients) is mainly based upon the systematic review given by Larsson et al. (Larsson K, Carlsen KH, Bonini S. Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction. In: Carlsen KH, Delgado L, Del Giacco S, editors. Diagnosis, prevention and treatment of exercise-related asthma, respiratory and allergic disorders in sports. Sheffield, UK: European Respiratory Journals Ltd, 2005:73–88) during the work of the Task Force. To assess the evidence of the literature regarding use of β2-agonists related to athletic performance, the Task Force searched Medline for relevant papers up to November 2006 using the present search words: asthma, bronchial responsiveness, exercise-induced bronchoconstriction, athletes, sports, performance and β2-agonists. Evidence level and grades of recommendation were assessed according to Sign criteria.
Results: Treatment recommendations for EIA and bronchial hyper-responsiveness in athletes are set forth with special reference to controller and reliever medications. Evidence for lack of improvement of exercise performance by inhaled β2-agonists in healthy athletes serves as a basis for permitting their use. There is a lack of evidence of treatment effects of asthma drugs on EIA and bronchial hyper-responsiveness in athletes whereas extensive documentation exists in treatment of EIA in patients with asthma. The documentation on lack of improvement on performance by common asthma drugs as inhaled β2-agonists with relationship to sports in healthy individuals is of high evidence, level (1+).
Conclusions: Exercise induced asthma should be treated in athletes along same principles as in ordinary asthma patients with relevance to controller and reliever treatment after careful diagnosis. There is very high level of evidence for the lack of improvement in athletic performance by inhaled β2-agonists
Recommended from our members
On the probability of Magnus Carlsen reaching 2900
No full textHow likely is it that Magnus Carlsen will achieve his goal of a 2900 Elo rating? At what level of play does Magnus have a reasonable chance of reaching the 2900 goal? These two questions are of great current interest to Magnus and the chess community. The probabilistic properties of Elo's rating system are well known, and together with a Brownian motion model of rating evolution, we use simulation-based methods to address these questions. Our model assesses that Magnus has a 4.5% chance of reaching 2900 if he continues his 2020–2022 level of play. However, this increases dramatically to 80% chance if he can repeat his hot streak performance of 2019 which is not an easy undertaking. The probabilities are intimately related to Elo's choice K-factor -factor used for grandmaster chess play. Finally, we conclude with a discussion of the policy issues involved with the choice of K-factor
Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN
No full textAim: The aims of part II is to review the current recommended treatment of exercise-induced asthma (EIA), respiratory and allergic disorders in sports, to review the evidence on possible improvement of performance in sports by asthma drugs and to make recommendations for their treatment.
Methods: The literature cited with respect to the treatment of exercise induced asthma in athletes (and in asthma patients) is mainly based upon the systematic review given by Larsson et al. (Larsson K, Carlsen KH, Bonini S. Anti-asthmatic drugs: treatment of athletes and exercise-induced bronchoconstriction. In: Carlsen KH, Delgado L, Del Giacco S, editors. Diagnosis, prevention and treatment of exercise-related asthma, respiratory and allergic disorders in sports. Sheffield, UK: European Respiratory Journals Ltd, 2005:73-88) during the work of the Task Force. To assess the evidence of the literature regarding use of beta(2)-agonists related to athletic performance, the Task Force searched Medline for relevant papers up to November 2006 using the present search words: asthma, bronchial responsiveness, exercise-induced bronchoconstriction, athletes, sports, performance and beta(2)-agonists. Evidence level and grades of recommendation were assessed according to Sign criteria.
Results: Treatment recommendations for EIA and bronchial hyper-responsiveness in athletes are set forth with special reference to controller and reliever medications. Evidence for lack of improvement of exercise performance by inhaled beta(2)-agonists in healthy athletes serves as a basis for permitting their use. There is a lack of evidence of treatment effects of asthma drugs on EIA and bronchial hyper-responsiveness in athletes whereas extensive documentation exists in treatment of EIA in patients with asthma. The documentation on lack of improvement on performance by common asthma drugs as inhaled beta(2)-agonists with relationship to sports in healthy individuals is of high evidence, level (1+).
Conclusions: Exercise induced asthma should be treated in athletes along same principles as in ordinary asthma patients with relevance to controller and reliever treatment after careful diagnosis. There is very high level of evidence for the lack of improvement in athletic performance by inhaled beta 2-agonists
C*-crossed products and shift spaces
No full textAbstractWe use Exel's C*-crossed products associated to non-invertible dynamical systems to associate a C*-algebra to arbitrary shift space. We show that this C*-algebra is canonically isomorphic to the C*-algebra associated to a shift space given by Carlsen [Cuntz–Pimsner C*-algebras associated with subshifts, Internat. J. Math. (2004) 28, to appear, available at arXiv:math.OA/0505503], has the C*-algebra defined by Carlsen and Matsumoto [Some remarks on the C*-algebras associated with subshifts, Math. Scand. 95 (1) (2004) 145–160] as a quotient, and possesses properties indicating that it can be thought of as the universal C*-algebra associated to a shift space.We also consider its representations and its relationship to other C*-algebras associated to shift spaces. We show that it can be viewed as a generalization of the universal Cuntz–Krieger algebra, discuss uniqueness and present a faithful representation, show that it is nuclear and satisfies the Universal Coefficient Theorem, provide conditions for it being simple and purely infinite, show that the constructed C*-algebras and thus their K-theory, K0 and K1, are conjugacy invariants of one-sided shift spaces, present formulas for those invariants, and present a description of the structure of gauge invariant ideals
- …
